Skip to main content

Find Clinical Trials

Home
Conditions
Stage III Skin Melanoma

Clinical trial condition

Stage III Skin Melanoma

Explore clinical trials studying Stage III Skin Melanoma. Study availability and eligibility vary by location and protocol.

6 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III Skin Melanoma trial results

Completed

Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma

NCT03028948

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +21 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

NCT03154190

Conditions: Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +146 more
Locations: Virginia K Crosson Cancer Center Fullerton, California, United States

View Trial Details

Completed

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

NCT03229278

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

NCT03112668

Conditions: Breast Diseases, Breast Neoplasms, Colonic Diseases, +80 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

NCT00387751

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma

NCT00866177

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details